๐ช๐ต๐ฒ๐ป ๐ถ๐ ๐ฐ๐ผ๐บ๐ฒ๐ ๐๐ผ ๐๐ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต, ๐ฒ๐ ๐ฝ๐ฒ๐ฟ๐ถ๐ฒ๐ป๐ฐ๐ฒ ๐บ๐ฎ๐๐๐ฒ๐ฟ๐.
Weโre a trusted scientific partner for sponsors advancing therapies for ulcerative colitis, Crohnโs disease, and related indications.
This depth of GI-focused scientific leadership allows us to address scientific and operational challenges with precision, accelerate timelines, and generate data sponsors and regulators trust.
Discover how our GI expertise can strengthen your program: https://t.co/HPrNMrjiOB
#GIIsOurWhy #IBDResearch #ClinicalTrials #Gastroenterology #CROLeadership
Need a CRO that understands the complexities of celiac disease? Alimentiv combines decades of GI expertise with a purpose-built, proven approach to trial design, imaging, and site selection that that recruit patients faster than average, plus a global network spanning 5,000+ sites across 60+ countries.
Weโve helped shape IBD endpoints and advanced GI therapies - now weโre applying that knowledge to accelerate celiac research to bring new therapies to patients, faster.
See how we can support your celiac trial. https://t.co/OX3fpkLbJL
#CeliacDisease #ClinicalTrials #GIResearch #CRO #Alimentiv
๐๐ฎ๐ฝ๐ฝ๐ #๐ฃ๐ฟ๐ถ๐ฑ๐ฒ ๐ ๐ผ๐ป๏ฟฝ๏ฟฝ๐ต ๐ณ๐ฟ๐ผ๐บ ๐๐น๐ถ๐บ๐ฒ๐ป๐๐ถ๐! ๐
Pride reminds us that belonging is at the foundation of our organization. We're proud to bring our whole selves to work, supported by our LGBTQ+ Employee Resource Group that provides education, advocacy, and connection.
Diversity in our workplace and in clinical research is key to the science we do.
๐ณ๏ธโ๐โง๏ธ๐ณ๏ธโโง๏ธ Wishing everyone a joyful, safe, and proud month.
#PrideMonth #Pride2026 #LGBTQ #InclusiveResearch #LoveIsLove
Celiac disease trials face regulatory and scientific challenges โ from a lack of validated endpoints to the difficulty of demonstrating clinical benefit.
Alimentiv brings deep GI expertise and country-specific regulatory insight to build the ideal start-up strategy. With decades of trial design and delivery experience, we help sponsors navigate these complexities with confidence.
From protocol development and submission through end-of-study reporting, we partner with you to build smarter trials that meet regulatory expectations and move therapeutic progress forward.
Explore more: https://t.co/OX3fpkLbJL
#CeliacDisease #ClinicalTrials #TrialDesign #RegulatoryStrategy #GIResearch #ClinicalDevelopment
In the complex field of clinical research, partnering with a specialized CRO is key. Alimentiv has over 30 years of GI-related experience and offers end-to-end clinical trial services.
Our unmatched expertise spans all trial phases, starting from clinical trial management to imaging and precision medicine. We partner with you to deliver innovative solutions for your studies.
Learn why we are the trusted partner for leading pharmaceutical & biotech companies: https://t.co/3cbkRFRObp
#Alimentiv #GIIsOurWhy #ClinicalTrials
๐ ๐๐จ๐ซ๐ฅ๐ ๐๐จ๐ฌ๐ข๐ง๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐ ๐๐ฌ๐จ๐ฉ๐ก๐๐ ๐ข๐ญ๐ข๐ฌ (๐๐จ๐) ๐๐๐ฒ was established in 2025 to raise awareness and drive action for those affected by this chronic and often underdiagnosed immune condition.
At Alimentiv, we support #EoE clinical research and are working to bring new therapies to patients.
๐ฌ Learn how weโre developing AI-based digital image analysis tools to improve histological assessments in EoE trials: https://t.co/FUDGJKEwLg
#EoEDay #UniteForEoE #GIIsOurWhy
Scientific leadership is the foundation of better GI trials. Thatโs why weโve built a leadership team, scientific advisor group, and global network of key opinion leaders (KOLs) with decades of GI research experience.
Our expert team guides clinical development strategies that deliver exceptional outcomes. Learn more about our scientific and therapeutic leadership: https://t.co/zTHW8sCKEB
#GIIsOurWhy #ClinicalResearch #Gastroenterology #ClinicalTrials #IBDResearch
On #ClinicalTrialsDay, we recognize the people who make clinical research possible and the importance of making it accessible to patients everywhere. ๐
GI disease affects patients on all continents. At Alimentiv, weโre proud to be a global company with an extensive site network โ we go where the disease is.
Judi Hall, VP, Global Resource Management, explains that itโs the infrastructure, expertise, and collaboration across regions that make GI trials possible.
Together, weโre working to expand access, accelerate discovery, and ultimately improve outcomes for patients living with GI disease around the globe.
#GIIsOurWhy #CTD2026 #ResearchRising
๐ช๐ต๐ ๐๐?
Because better data leads to better outcomes โ and patients deserve nothing less.
For more than 30 years, Alimentiv has led the science of GI clinical trials. From global trial design and patient recruitment to imaging, histopathology, and endpoints you can trust, our purposeโbuilt GI infrastructure delivers the rigor, consistency, and partnership sponsors need to accelerate development with confidence.
Weโre proud to have supported over 70% of IBD compounds in development โ and weโre just getting started. โจ
๐๐ ๐๐ ๐ข๐๐ฟ ๐ช๐ต๐. Watch our story.
#GIIsOurWhy #Alimentiv #GIResearch #ClinicalTrials #DrugDevelopment #IBD
For over 30 years, Alimentiv has led the science of gastroenterology clinical research โ ๐๐๐ฝ๐ฝ๐ผ๐ฟ๐๐ถ๐ป๐ด >๐ณ๐ฌ% ๐ผ๐ณ ๐๐๐ ๐ฐ๐ผ๐บ๐ฝ๐ผ๐๐ป๐ฑ๐ in development, and building a global network of ๐ฑ,๐ฌ๐ฌ๐ฌ+ ๐๐ถ๐๐ฒ๐ ๐ฎ๐ฐ๐ฟ๐ผ๐๐ ๐ฒ๐ฌ+ ๐ฐ๐ผ๐๐ป๐๐ฟ๐ถ๐ฒ๐.
We donโt just run trials, we advance the science behind them. ๐ข๐๐ฟ ๐๐ป๐บ๐ฎ๐๐ฐ๐ต๐ฒ๐ฑ #๐๐ ๐๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ฑ๐ฒ๐น๐ถ๐๐ฒ๐ฟ๐ ๐๐ต๐ฒ ๐ณ๐ผ๐ฐ๐๐ ๐ฎ๐ป๐ฑ ๐ฑ๐ฎ๐๐ฎ ๐พ๐๐ฎ๐น๐ถ๐๐ ๐ฟ๐ฒ๐พ๐๐ถ๐ฟ๐ฒ๐ฑ ๐ณ๐ผ๐ฟ ๐ฒ๐ ๐ฐ๐ฒ๐ฝ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ผ๐๐๐ฐ๐ผ๐บ๐ฒ๐.
See how we advance GI science: https://t.co/oliMqFUb6I
#GIIsOurWhy #ClinicalTrials #ClinicalResearch #Alimentiv
๐ช๐ต๐ฒ๐ป ๐ถ๐ ๐ฐ๐ผ๐บ๐ฒ๐ ๐๐ผ ๐๐ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต, ๐ฒ๐ ๐ฝ๐ฒ๐ฟ๐ถ๐ฒ๐ป๐ฐ๐ฒ ๐บ๐ฎ๐๐๐ฒ๐ฟ๐.
Weโre a trusted scientific partner for sponsors advancing therapies for ulcerative colitis, Crohnโs disease, and related indications.
This level of involvement reflects decades of GI-focused scientific leadership that help us navigate complexity, accelerate timelines, and generate that data sponsors and regulators trust.
Discover how our GI expertise can strengthen your program: https://t.co/HPrNMriKZ3
#GIIsOurWhy #IBDResearch #ClinicalTrials #Gastroenterology #CROLeadership
DDW marked the second conference where we brought GI Is Our Why to life โ this time, for the entire GI community.
This year was especially meaningful as we unveiled Alimentivโs refreshed brand and formally introduced our brand story: ๐๐ ๐๐ ๐ข๐๐ฟ ๐ช๐ต๐ โ a reflection of our deep commitment to advancing GI science across the full spectrum of the gastroenterology field.
Thank you to everyone who stopped by our booth, joined our sessions, and shared this milestone with us. Your engagement and collaboration continue to fuel innovation in GI research and reinforce the purpose that drives everything we do.
Missed us at DDW? No problem โ you can still connect with our GI experts: https://t.co/bn5CmM26AZ
We'll see you next year at #DDW2027 in Washington, D.C.! ๐๏ธ
#GIresearch #DDW2026 #Alimentiv #GIIsOurWhy
A gluten-free diet has long been the only option for people with celiac disease โ but it isnโt enough. The need for evidence-based therapies is growing.
At Alimentiv, we bring deep GI expertise, validated outcomes measures, centralized imaging and proven trial design to advance new therapeutic options that can change lives.
Through our global research network and operational excellence, weโre enabling sponsors to run trials smarter and move the field toward more meaningful outcomes for patients with celiac disease.
Explore our celiac focus: https://t.co/OX3fpkLbJL
#CeliacDisease #ClinicalTrials #GIResearch #BeyondTheDiet #Alimentiv
Weโre live at #DDW2026!
Stop by booth 4651 to learn how your next trial can benefit from:
โ๏ธ30+ years of GI expertise
๐ Trusted for >70% of IBD compounds in development
๐ 5000+ sites in 60+ countries
๐ Industry-leading imaging solutions, central reading & access to AI imaging technologies
๐ฌ State-of-the-art accredited histopathology lab and biomarker discovery
#GIIsOurWhy #Alimentiv #ClinicalResearch
๐๐ผ๐ป'๐ ๐ณ๐ผ๐ฟ๐ด๐ฒ๐ ๐๐ผ ๐ฎ๐๐๐ฒ๐ป๐ฑ ๐๐ต๐ถ๐ ๐ถ๐ป๐๐ถ๐ด๐ต๐๐ณ๐๐น ๐ฝ๐ผ๐๐๐ฒ๐ฟ ๐๐ฒ๐๐๐ถ๐ผ๐ป ๐ฎ๐ #๐๐๐ช๐ฎ๐ฌ๐ฎ๐ฒ!
@vip@vipuljairath will be sharing results from the VECTORS week 14 interim analysis which show early efficacy of vedolizumab in patients with moderately to severely active #CrohnsDisease.
๐๐๐ญ๐: May 4, 2026
๐๐ข๐ฆ๐: 12:30โ1:30 PM CDT
๐๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐ข๐ญ๐ฅ๐: Controlled Clinical Trials of IBD Treatment
๐๐จ๐ฌ๐ญ๐๐ซ: Mo1517
See more posters: https://t.co/wDOpFNLFqi
#IBD #Alimentiv #GIIsOurWhy
๐๐ผ๐ฟ ๐บ๐ฎ๐ป๐ ๐ผ๐ณ ๐๐ ๐ฎ๐ ๐๐น๐ถ๐บ๐ฒ๐ป๐๐ถ๐, ๐ผ๐๐ฟ ๐๐ผ๐ฟ๐ธ ๐ถ๐ ๐ป๐ผ๐ ๐ผ๐ป๐น๐ ๐ฝ๐ฟ๐ผ๐ณ๐ฒ๐๐๐ถ๐ผ๐ป๐ฎ๐น; ๐ถ๐โ๐ ๐ฝ๐ฒ๐ฟ๐๐ผ๐ป๐ฎ๐น.
It lives in the conversations we carry home, the family members we think about when we read a protocol, and the quiet reason we chose GI.
This #CeliacAwarenessMonth, we're launching a new series: ๐ข๐ป๐ฒ ๐ฃ๐๐ฟ๐ฝ๐ผ๐๐ฒ, ๐ ๐ฎ๐ป๐ ๐ฆ๐๐ผ๐ฟ๐ถ๐ฒ๐ โ an opportunity to hear from the people behind our work, including our Chief Operations Officer Stephanie Gonzalez โ whose daughter lives with celiac disease, and whose experience shapes what she believes this work must deliver.
Because behind every biopsy scored, every endpoint validated, every trial that moves forward โ there are real patients waiting for better answers.
That's what drives us. That's why GI is our focus.
#GIIsOurWhy #CeliacDisease #ClinicalTrials #CeliacAwarenessMonth
๐ก๐ผ ๐ผ๐ป๐ฒ ๐ต๐ฎ๐ ๐ฑ๐ผ๐ป๐ฒ ๐บ๐ผ๐ฟ๐ฒ ๐๐ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐ฟ๐ถ๐ฎ๐น๐ ๐๐ต๐ฎ๐ป ๐๐น๐ถ๐บ๐ฒ๐ป๐๐ถ๐.
That experience is more than a number โ it reflects decades of scientific leadership, deep therapeutic expertise, and longstanding partnerships across the global GI community.
While generalist CROs treat GI as part of a broader portfolio, Alimentiv brings full-spectrum, GI-exclusive expertise to every phase of clinical development. Weย bringย unmatched GI expertise toย every endpoint, every site, every phase.ย That is how we build exceptional outcomes.
Sponsors who partner with Alimentiv gain:
๐ฌ A specialized GI CRO with 30+ years of unmatched trial experience, having supported ๐บ๐ผ๐ฟ๐ฒ ๐๐ต๐ฎ๐ป ๐ณ๐ฌ% ๐ผ๐ณ ๐๐๐ ๐ฐ๐ผ๐บ๐ฝ๐ผ๐๐ป๐ฑ๐ ๐ถ๐ป ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐
๐ฅ Access to a global network of GI KOLs and investigators built over decades
๐ End-to-end clinical services supported by ๐ฑ,๐ฌ๐ฌ๐ฌ+ ๐๐ถ๐๐ฒ๐ ๐ถ๐ป ๐ฒ๐ฌ+ ๐ฐ๐ผ๐๐ป๐๐ฟ๐ถ๐ฒ๐
๐ฏ The scale, structure, and discipline required to deliver optimal trial outcomes
๐ช๐ต๐ฒ๐ป ๐๐ ๐๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ ๐ถ๐ ๐ฐ๐ผ๐บ๐ฝ๐น๐ฒ๐ ๐ฎ๐ป๐ฑ ๐๐ต๐ฒ ๐๐๐ฎ๐ธ๐ฒ๐ ๐ฎ๐ฟ๐ฒ ๐ต๐ถ๐ด๐ต, ๐๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐บ๐ฎ๐ธ๐ฒ๐ ๐๐ต๐ฒ ๐ฑ๐ถ๐ณ๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ.
Connect with Alimentiv at #DDW2026, May 2โ5 in Chicago.
#GIIsOurWhy #ClinicalResearch #CRO
๐ฅผ Donโt miss our #AI Learning Lab at #DDW2026!
Alimentiv and @AcelaBioLab's CAP-accredited histopathology lab is advancing histology analysis through digital AI innovation!
We will be showcasing our AI pathology-assisted scoring tools for IEL quantification in celiac disease. Find out how AI augmentation can simplify and standardize histologic scoring in Celiac studies.
๐ @DDWMeeting, Chicago, IL
๐๏ธ May 3, 11:30 AM-12:00 PM
๐๏ธ May 4, 12:30-1:00 PM
See the full schedule: https://t.co/GaPuSZUFkm
#CeliacDisease #DigitalPathology #Alimentiv #AcelaBio #DDW2026
VERDICT is the first randomized controlled treat-to-target trial in #UlcerativeColitis.
This trial, sponsored and conducted by Alimentiv in collaboration with @TakedaPharma, will provide the only prospective data on optimal treatment targets that will aim to help inform clinical guidelines, regulatory endpoints, and drug development for UC.
#ClinicalTrials #Alimentiv #GIIsOurWhy